As regulators push to phase out animal testing, Charles River’s Steve Bulera notes that widespread implementation of ...

Dynavax has revealed outcomes from the initial part of its Phase I/II trial, comparing its shingles vaccine Z-1018 against ...

If approved, AbbVie's Rinvoq could be set to dominate the alopecia market after exhibiting better efficacy than main ...

This webinar offers essential tools and insights to help organisations confidently navigate the BioSecure Act, ensuring they ...